AC
LENZ

AXQ Capital’s LENZ Therapeutics LENZ Stock Holding History

AXQ Capital’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72.4K Sell
12,744
-41,824
-77% -$337K 0.01% 885
2026
Q1 		$499K Buy
54,568
+34,729
+175% +$488K 0.06% 418
2025
Q4 		$317K Buy
19,839
+14,741
+289% +$430K 0.07% 425
2025
Q3 		$237K Buy
+5,098
New +$187K 0.09% 396

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

AXQ Capital's LENZ Position: Q2 2026 in Review

AXQ Capital reduced its LENZ Therapeutics (LENZ) stake by 77% in Q2 2026, selling an estimated $337K and leaving 12,744 shares worth $72.4K. The position accounts for 0.01% of the portfolio, ranked #885.

AXQ Capital first reported a position in LENZ in Q3 2025 and has held it in 4 quarters since. The position peaked at $499K in Q1 2026. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • AXQ Capital held 12,744 shares of LENZ Therapeutics worth $72.4K as of Q2 2026.
  • AXQ Capital sold 41,824 LENZ Therapeutics shares in Q2 2026, an estimated $337K.
  • LENZ Therapeutics made up 0.01% of AXQ Capital's portfolio in Q2 2026, its #885 holding.
  • AXQ Capital first reported a position in LENZ Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • AXQ Capital's LENZ Therapeutics position peaked at $499K in Q1 2026.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.